Integrating the GRIm score with microenvironmental parameters—such as PD-L1 expression, tumor-infiltrating lymphocyte (TIL) density, and tumor–stroma ratio (TSR)—provides improved prognostic discrimination by jointly reflecting systemic inflammation, host nutritional status, and stromal–immune dynamics. Here, CD274 is linked to neoplasm.